Feasibility Study of a Transdermal Continuous Glucose Monitoring (CGM) System in Diabetic Patients

NCT05133973 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DEVICE: FiberSense CGM

Sponsor

EyeSense GmbH